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■ LETTER TO THE EDITOR ■
Recurrence of carcinoma of the uterine cervix mainly
occurs locally or regionally after treatment. The most
frequent recurrence sites are the parametrium, pelvic
lymph nodes, and vagina. Distant metastasis usually
occurs in the lungs, bone, and liver. The incidence of
incisional scar recurrence from cervical carcinoma is
low, ranging from 0.1% to 2% [1].
We present a case of scar metastasis in a patient
2.5 years after a radical hysterectomy and chemotherapy
for cervical cancer.
A 45-year-old woman presented to our clinic with a
mass over a prior surgical scar. Two and a half years
earlier, she had undergone a radical hysterectomy and
pelvic lymph node dissection via a Pfannenstiel incision
for treatment of well-differentiated stage 1b squamous
cell carcinoma of the uterine cervix. The pathology re-
port confirmed the presence of a 2.5-cm squamous
cell carcinoma with parametrial involvement, but the
lymph nodes were negative and there was a clear surgi-
cal margin. The patient refused postoperative adjuvant
chemoradiation therapy at that time.
On examination, a nodular tumor of 3×3.5 cm
was noted in the scar of the previous Pfannenstiel inci-
sion. No locoregional recurrence was found in the vagi-
nal vault or pelvis after the patient was evaluated with
a pelvic examination, Pap smear, and computed tomo-
graphic scan. An irregular mass measuring 3.3×3.5 cm
arising from the scar extending to the right rectus
abdominis muscle was noted on abdominal ultrasound.
Local excision of the tumor was then performed. The
pathology report confirmed a metastatic squamous
cell carcinoma (Figure). Chemotherapy with cisplatin
(40 mg/m2) on day 1 plus topotecan (0.6 mg/m2) on
days 1 to 3 every 3 weeks was administered. Unfortu-
nately, another tumor, measuring 5×3 cm, recurred at
the upper edge of the second time of operation after
five courses of chemotherapy. Wide local excision of
the tumor of the superficial fascia of the right rectus
abdominis muscle and mesh repair of the abdominal
wall were subsequently performed. Two courses of post-
operative adjuvant chemoradiation consisting of radio-
therapy of 5,000 cGy and chemotherapy with cisplatin
75 mg/m2 at 3-week intervals were also administered.
The patient did well on follow-up and had had 
no evidence of disease at 14 months since her last
treatment.
Cervical carcinoma metastasis to the skin is an
uncommon event. To date, fewer than 35 cases have
been reported [2]. Cancers of the colon, gall bladder,
kidneys, ovaries and urinary bladder are known to give
rise to surgical scar recurrence [3]. The possible mech-
anisms of developing recurrence at the surgical scar may
be by direct seeding of tumor cells, or by hematoge-
nous or lymphogenous spread. Retrograde spread of
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Figure. Scar recurrence of squamous cell carcinoma with
keratin pearl formation (hematoxylin and eosin, 40×).
Taiwan J Obstet Gynecol • September 2008 • Vol 47 • No 3 349
Incisional Scar Recurrence from Cervical Carcinoma
tumor cells due to lymphatic obstruction was suggested
by Malfetano [4]. Imachi and coworkers reported that
most tumor cells can also be found in dilated lymphat-
ics of skin lesions [5]. These and other reports of cervi-
cal cancer recurrence at drainage sites have involved
midline incision scars [6]. In our case, recurrence in
the superficial fascia at the lateral margin of the rectus
abdominis muscle was noted. The lymphatic drainage
of this site was via the inferior epigastric chain. This
drainage might have been obliterated following pelvic
lymph node dissection.
The possibility of direct tumor seeding during the
operation cannot be ruled out. Direct spread to an
incision has an uncommon recurrence at laparoscopic
port sites [7,8]. Interestingly, recurrence at a cesarean
section scar made prior to a diagnosis of cervical can-
cer 24 years later has been reported [2]. Owing to the
lack of lymphatic drainage in this area, the probability
of hematogenous spread of cervical cancer is also pos-
sible. In our case, the surgical scar for the radical hys-
terectomy was made using a Pfannenstiel incision. This
incision supposedly provides a smaller surgical field
compared with a midline longitudinal incision, which
may require more vigorous traction of the abdominal
wall intraoperatively. While the cause of the scar recur-
rence in this case remains unclear, direct tumor seeding
via vigorous manipulation and traction of the smaller
operative field is certainly a possibility.
Because of the rarity of incisional cancer recurrence
[9,10], optimal management of this condition is still
unclear. Treatment should be individualized based on the
extent of the disease. For distant metastasis such as to
the liver, lung, bone and abdominal lymph nodes, there
is currently no curative treatment. Localized recurrent
disease with no other metastatic sites has been treated
with surgery, and radiotherapy alone or in combina-
tion with chemotherapy. Cisplatin with 5-fluorouracil
and doxorubicin (Adriamycin; Pharmacia & Upjohn,
MI, USA) in addition to radiotherapy was used to treat
a patient with episiotomy scar recurrence [10]. Chemo-
therapy with paclitaxel, ifosfamide and cisplatin was
well tolerated in one study [2]. In that case, surgery
was the mainstay of the treatment, followed by concur-
rent chemoradiation with weekly cisplatin treatment.
The prognosis of cervical cancer patients with sur-
gical scar metastasis is generally poor, with the length
of survival ranging from 1 to 37 months (mean, 8.5
months) [5]. A better prognosis, however, has been
reported in a patient with episiotomy scar metastasis
[10]. Therefore, in the absence of recurrence in deeper
tissues or distant metastasis, as was the case in our
patient, a longer patient survival in the presence of such
superficial scar recurrence may be anticipated [5].
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